RGT 12.1% 25.5¢ argent biopharma limited

Ann: FDA Approval Granted and First US Distribution Deal Signed-MXC.AX, page-175

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 201 Posts.
    lightbulb Created with Sketch. 35
    Cbyrne11, as a clinical pharmacist, I can tell you that naturally-derived/plant-based medicines are able to largely by-pass the 'research+design' phase of 10-20 years because of regulatory loopholes. Furthermore, even if what you said was true, a superfluous amount of evidence already exists for its use in a myriad of conditions such as pain and epilepsy, albeit, they are the results of studies found in research performed by other countries - this does not discount the fact that their clinical trials are indeed valid for use regarding TGA's decisions; much the contrary as this allows a meta-analysis of randomised-controlled trials to be performed, which is, the GOLD STANDARD when it comes to releasing a new drug on the market. I can also tell you that the evidence for medicinal cannabis is overwhelming and it is only a matter of time before it becomes the next 'penicillin'.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.035(12.1%)
Mkt cap ! $13.83M
Open High Low Value Volume
25.5¢ 25.5¢ 25.5¢ $465 1.824K

Buyers (Bids)

No. Vol. Price($)
2 4408 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 8264 3
View Market Depth
Last trade - 12.38pm 11/11/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.